Licensed Practical Nurse in Mc Gehee, AR Accepting Medicare
4 Licensed Practical Nurse nurses found. Showing 1 - 4
 Tamara Ann Wargo, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 901 S 3rd St, Mc Gehee, AR 71654 Phone: 870-222-3806 Fax: 870-222-3984 |
Kathalene Brooks Williams, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 515 Holly St, Mc Gehee, AR 71654 Phone: 870-222-4500 Fax: 870-222-4505 |
Sylvia Morrison, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 901 S 3rd St, Mc Gehee, AR 71654 Phone: 870-222-3805 Fax: 870-222-3984 |
Lori Angela Snow, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 901 S 3rd St, Mc Gehee, AR 71654 Phone: 870-222-3805 Fax: 870-222-3984 |
News Archive
New study indicates that lead concentration may be higher below soil surface
A newly published analysis of data from hundreds of soil samples from 31 properties around southern Rhode Island finds that the lead concentration in soil at the surface is not always a reliable indicator of the contamination a foot deeper.
Catheter coating: an interview with Dr. Hinke Malda, Director of Medical Coatings, DSM Biomedical
DSM's biomedical work brings new material innovation to market through the development of novel materials-based solutions that meet the present and future needs of the medical device and pharmaceutical industries.
ADDF awards grant to support initiation of AGB101 Phase 3 trial for aMCI treatment
The Alzheimer's Drug Discovery Foundation announced today a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. The grant will support the initiation of an FDA-registered Phase 3 clinical trial of AGB101, a new therapeutic treatment for amnestic mild cognitive impairment (aMCI).
CAS Medical awarded two new U.S. patents
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Urine proteome pattern may predict coronary artery disease
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
› Verified 4 days ago